Navigation Links
ViewRay Incorporated Closes $15M Tranche of Series B Financing and Announces Partnership with Siemens AG
Date:4/13/2009

OAKWOOD VILLAGE, Ohio, April 14 /PRNewswire/ -- ViewRay Incorporated, a medical device company, announces the close of the second tranche of their $25M Series B financing. Funding was triggered by the company's achievement of a major milestone towards the development of their image guided cancer therapy device, the Renaissance(TM) System. The financing was led by OrbiMed Advisors and Fidelity Biosciences, and was joined by Aisling Capital and Kearny Venture Partners.

"These funds will allow us to continue developing our novel radiation therapy device for the treatment of cancer patients. We believe our system's simultaneous real-time volumetric imaging may provide a tremendous clinical advantage over systems in use today," said Dr. James F. Dempsey, founder and inventor of the technology, and Chief Scientific Officer of the company.

Additionally, the company is announcing that it has entered into an exclusive development and supply agreement with Siemens AG, Healthcare Sector for magnetic resonance imaging (MRI) technology. This collaboration will accelerate the development of ViewRay's Renaissance(TM) System.

"Siemens is a recognized leader in the field of MRI and their expertise in this area will enable us to incorporate state-of-the-art imaging technology into our product," said Dr. John L. Patrick, Senior V.P. of Engineering.

"We are excited to work with ViewRay to explore the capabilities of MR beyond diagnostics and into the field of radiation therapy with a clear goal to improve therapy treatment to the benefit of the patient," said Walter Marzendorfer, head of Magnetic Resonance, Siemens AG, Healthcare Sector.

About ViewRay Incorporated:

ViewRay Incorporated is developing an advanced system to treat cancer patients: the world's first real-time MRI guided radiation therapy device. The Renaissance(TM) System technology will continuously image the patien
'/>"/>

SOURCE ViewRay Incorporated
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
2. MultiCell Technologies Signs Worldwide Exclusive License Agreement With Corning Incorporated
3. Accuray Incorporateds CEO to Speak at Piper Jaffray 19th Annual Health Care Conference
4. Genta Incorporated to Present at Lazard Capital Markets 4th Annual Healthcare Conference
5. Genta Incorporated to Present at the BIO CEO & Investor Conference
6. Auditors for Genta Incorporated Express Going Concern Qualification
7. Genta Incorporated Announces First Quarter 2008 Financial Results and Corporate Highlights
8. Accuray Incorporateds CEO to Speak at CitiGroup Healthcare Conference
9. Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights
10. Accuray Incorporated to Host Investor and Analyst Meeting at ASTRO
11. Accuray Incorporateds CEO to Speak at UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 15, 2014 DTS Language Services, Inc ... Web Portal for Life Science organizations who need document translations. ... subject matter of their documents in advance with a selection ... time-to-delivery of translations, often a critical factor in clinical and ...
(Date:1/14/2014)... (PRWEB) January 14, 2014 Date: Friday, April ... Location: Warrington Country Club, 1360 Almshouse Road, Warrington, Pa. ... nonprofit organization solely dedicated to finding a cure for hepatitis ... worldwide, will host its annual Crystal Ball on Friday, April ...
(Date:1/14/2014)... EquitiesIQ, a leading informational research provider, has ... an emerging biomedical company acquiring, developing, manufacturing, and marketing ... Free report download: http://equitiesiq.com/reports/alliqua/ , In late ... and Board, which launched the company’s new strategy to ...
(Date:1/14/2014)... , Jan. 14, 2014  RXi Pharmaceuticals Corporation (OTCQX: ... and commercializing innovative therapies addressing major unmet medical ... received the Notice of Allowance from the United ... self-delivering RNAi compounds (sd-rxRNA®), for the treatment of ...
Breaking Biology Technology:DTS Improves Efficiency for Life Science Document Translations 2Hepatitis B Foundation to Host Annual Crystal Ball Gala 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 2RXi Pharmaceuticals Receives US Notice of Allowance for a Key Patent Relating to its Self-Delivering Technology with sd-rxRNAs targeting CTGF, including RXI-109, for the Treatment of Fibrotic Disorders 3
... 23, 2012 SiREM ( www.siremlab.com ) and ... signing of a Sales Agency Agreement between the ... Tersus Environmental will market, promote and sell SiREM,s ... as well as Gene-Trac® molecular testing services and ...
... Mich. and AMSTERDAM, Feb. 23, 2012   Rubicon ... sample-specific pre-analytical processes to improve the capabilities ... platforms, today announced a clinical supply agreement ... TransPLEX® whole genome RNA amplification technology.  Agendia ...
... Inc. (OTCBB: AMBS), a biotechnology company developing MANF, ... Gerald E. Commissiong, President and CEO, will present ... National Investment Banking Association (NIBA) conference on Thursday, ... Pavillon Hotel in New Orleans, LA. Mr. Commissiong ...
Cached Biology Technology:Rubicon Genomics and Agendia Sign Agreement for Use of TransPLEX® Whole Genome RNA Amplification Technology With Symphony™ Cancer Diagnostics 2Rubicon Genomics and Agendia Sign Agreement for Use of TransPLEX® Whole Genome RNA Amplification Technology With Symphony™ Cancer Diagnostics 3Amarantus BioSciences to Present at the 2012 National Investment Banking Association Conference in New Orleans 2
(Date:4/17/2014)... study suggests that fish consumption advisories for expecting ... long-lived contaminants like persistent organic pollutants (POPs). ... researchers including University of Toronto Scarborough PhD student ... how different levels of environmental contamination, a mother,s ... in the body influenced exposure in her children. ...
(Date:4/17/2014)... hundred births, Down syndrome - or trisomy 21 - ... It results from a chromosomal abnormality where cells of ... (1% of the human genome). A study conducted by ... Genetic Medicine and Development at the University of Geneva ... shed light on how the extra chromosome 21 upsets ...
(Date:4/17/2014)... in bone marrow need to produce hydrogen sulfide in ... to a new study from the Center for Craniofacial ... of USC. , Professor Songtao Shi, principal investigator on ... by the cells governs the flow of calcium ions. ... that results in osteogenesis, or the creation of new ...
Breaking Biology News(10 mins):Fish consumption advisories fail to cover all types of contaminants 2Trisomy 21: How an extra little chromosome throws the entire genome off balance 2Trisomy 21: How an extra little chromosome throws the entire genome off balance 3
... PHILADELPHIA People with the heritable disorder of the ... develop basal cell carcinoma of the skin may have ... According to results of a placebo-controlled, randomized, double-blind, Phase ... inhibiting the development of basal cell carcinomas in a ...
... being recognized for devising a new way to study a ... investigating its role in the communication of important genetic messages ... Last year, the team, led by J. Andrew Hockert, at ... Health Science Center School of Medicine, put in its crosshairs ...
... HILL Bacteria can swim, propelling themselves through fluids using ... strolling along solid surfaces using little fibrous legs called pili. ... establish the infections such as meningitis that cause ... Now researchers at the University of North Carolina at Chapel ...
Cached Biology News:Celebrex inhibited the burden of skin cancer in high-risk patients 2Researchers pin down long-elusive protein that's essential to 'life as we know it' 2Researchers pin down long-elusive protein that's essential to 'life as we know it' 3A single atom controls motility required for bacterial infection 2A single atom controls motility required for bacterial infection 3
... the cost-effective solution for entry level imaging ... research imaging tasks, MetaVue enables time lapse, ... analysis. Compatibility with MetaMorphs extensive and ... has the power to drive motorized microscopes, ...
... for microRNA expression profiling ,miRCURY ... Locked Nucleic Acid (LNA) technology to provide ... short microRNA (miRNA) targets. miRCURY LNA Arrays ... RNA (no need for microRNA enrichment) labeled ...
... XL extends the MSn performance of the ... tools to generate extensive structural information for ... , Multiple dissociation techniques (PQD, ETD, ... unpredicted metabolites , Fast polarity switching for ...
For removal of the zona pellucida. Sterile, Mouse Embryo tested...
Biology Products: